Ming-Ching Lee

Visiting Investigator

Ming-Ching Lee

Visiting Investigator

Awards and Scholarships

Taiwan Veterans General Hospital Research Scholarship

Current Employment

Attending Thoracic Surgeon, Taichung Veterans General Hospital, Taichung, Taiwan.

Publications

Manuscripts

  • Lee MC, Buitrago DH, Kadota K, Jones DR, Adusumilli PS. Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas. Lung Cancer Manag. 2014 Jun 1;3(3):245-253. (PMC4156131) PMID: 25202339.
  • Lee MC, Kadota K, Buitrago DH, Jones DR, Adusumilli PS. Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts. J Thorac Dis 2014 Oct;6(Suppl 5):S568-80. Review. (PMC4209386) PMID: 25349708.
  • Lee MC, Buitrago DH, Kadota K, Ujiie H, Woo K, Sima CS, Travis WD, Jones DR, Adusumilli PS. The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer. Oncoimmunology. 2014 Nov 1;3(11):e967142. (PMC4368147) PMID: 25941595
  • Ujiie H, Kadota K, Chaft JE, Buitrago DH, Sima CS, Lee MC, Huang J, Travis WD, Rizk NP, Rudin CM, Jones DR, Adusumilli PS. Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival. J Clin Oncol. 2015 (in press)
  • Kadota K, Buitrago DH, Lee MC, Villena-Vargas J, Sima CS, Jones DR, Travis WD, Adusumilli PS. Tumoral CD10 Expression Correlates with High-Grade Histology and Increases Risk of Recurrence in Patients with Stage I Lung Adenocarcinoma. Lung Cancer. 2015 Jun 15. pii: S0169-5002(15)00288-3. (PMC4156131) PMID: 26141216.

Abstracts/Presentations

  • Lee MC, Kadota K, Ujiie H, Travis WD, Rusch VW, Sadelain M, Adusumilli PS. The Tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer: Implications for immunotherapy. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer, October 27-30, 2013, Sydney, Australia.
  • Lee MC, Buitrago D, Kadota K, Sima CS, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Incremental association of solid histological subtype with predominant immunoinhibitory microenvironment in stage I lung adenocarcinoma (Tumor IL-7R and stromal FoxP3). International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer, October 27-30, 2013, Sydney, Australia.
  • Bograd A, Kadota K, Lee MC, Sarkaria IS, Rusch VW, Travis WD, Adusumilli PS. Tumoral neutral endopeptidase (CD10) expression predicts risk of recurrence, and further stratify intermediate-grade histology patients in stage I lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer, October 27-30, 2013, Sydney, Australia.